In gastric cancer, miR-129-5p targets two sites in WWP1 CDS whereas miR-129-3p targets the 3′-UTR of WWP1 to inhibit WWP1-mediated proliferation and migration in vitro and tumor growth in vivo [139]. Here, WWP1 is linked to neoplasm.